Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| CODEXIS (NASDAQ: CDXS) | Delayed: 1.31 +0.02 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.29 | 52 Week High | $5.25 | |||
| Open | $1.29 | 52 Week Low | $2.93 | |||
| Day High | $1.33 | P/E | N/A | |||
| Day Low | $1.29 | EPS | $-1.25 | |||
| Volume | 410,437 | |||||
